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Supplemental Methods
Crystallization and structure determination of InhA ternary complexes with PT92, PT10, PT91 and PT155. Crystals of the ternary complex formed between InhA, NAD+ and PT92 were obtained by incubating 5 mg/mL of InhA with 2 mM NAD + and 800 µM PT92 in 8% DMSO for 2 hr at RT before mixing with an equal volume of reservoir solution containing 100 mM Bis-tris pH 6.4, 200 mM NaCl, 14% PEG 3350 and 4% DMSO in a hanging drop. Before freezing, the crystals were cryo-protected in the solution containing 100 mM Bis-tris pH 6.4, 310mM NaCl, 16% PEG 3350, 25% DMSO, 2 mM NAD + and 800 µM PT92. Table S1 .
Computational Methods
Initial pose of inhibitors. The initial pose of PT70 was taken from the first monomer of the InhA:NAD + :PT70 complex (PDB ID: 2X23 (4)). For the other inhibitors, the initial poses were generated by the DOCK 6.3(5) suite of docking software. The procedure for preparing the binding-site has been described previously.(6) Briefly, a molecular surface of InhA was computed using the program DMS.(7) The program SPHGEN in DOCK 6.3 was used to generate a set of spheres in regions where the inhibitor atoms could potentially interact favorably with the receptor, and 39 spheres were used to guide inhibitor placement during flexible docking. The grid file was computed with a 0.3 Å grid space using the program GRID in DOCK 6.3. Default parameters were then used in the flexible docking. We assumed that the other analogues adopted similar positions to that found for PT70. Thus, the results with the lowest RMSD value in the diphenyl ether moiety were chosen as the initial structures for MD runs. (8)), respectively. AMBER ff99SB(9) and GAFF(10) force field parameters were assigned to the protein and inhibitor, respectively. The force field parameters of the cofactor NAD + were taken from other studies. (11, 12) The partial atomic charges of the inhibitors were computed using Gaussian98 (13) with the HF/6-31G* basis set, followed by a two-stage RESP fitting approach ( separately using the following procedures. The first equilibration step involved 10,000 steps of steepest descent minimization with 100 kcal mol -1 Å -2 restraints on all the atoms except the water molecules and hydrogen atoms. The second step involved heating the system from 100 to 300 K under constant volume conditions over 100 ps with 100 kcal mol -1 Å -2 restraints on nonwater and non-hydrogen atoms, followed by 100 ps with the same restraints at a constant temperature of 300 K and at 1 atm of pressure. The third step was 250 ps MD with restraint weight of 10 kcal mol -1 Å -2 on the non-water and non-hydrogen atoms at constant temperature of 300 K and 1 atm pressure. The following steps only restrained the backbone atoms and gradually reduced the restraint weight from 10 to 0.1 kcal mol -1 Å -2 at constant temperature of 300 K and 1 atm of pressure. This was carried out by 100 ps with 10 kcal mol -1 Å -2 restraint, followed by 100 ps with 1 kcal mol -1 Å -2 restraint, and 100 ps with a 0.1 kcal mol -1 Å -2 restraint.
The last step of the equilibration was 250 ps of unrestrained MD.
PNEB simulation. The protocol for generation of conformational change pathways and associated free energy profiles using PNEB and umbrella sampling was adapted from our recent study of DNA damage recognition pathways. for another 500 ps ( Figure S10 ). There was no significant change in the free energy from 1ns run, thus 500ps umbrella sampling were run for other complexes. There is no significant change in the free energy from 1 st 500ps, 2 nd 500ps and 1ns runs.
